NBIX vs TTWO · P/E 45, rev $1.77B vs rev $6.66B
Neurocrine Biosciences Inc (NBIX) versus Take-Two Interactive Software Inc (TTWO) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Take-Two Interactive Software Inc (TTWO) is a electronic gaming & multimedia company listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported TTWO revenue for 2026-03-31 was $6.66B. Net income was -$298.2M. Revenue was up 18.2% from 2025-03-31 to 2026-03-31. TTWO currently screens at market cap $42.34B.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. TTWO currently screens at market cap $42.34B.
Not investment advice. Open the NBIX and TTWO stock pages for the full models.
Not investment advice.